date:Apr 28, 2014
te health marker the International Prostate Symptom Score (IPSS) compared with a placebo.
Improvements in the IPSS were more marked as the intake was increased, with a 250mg daily dose of Flowens providing a 25% improvement and a 500mg daily dose offering a 44% improvement.
This trial demonstrates that Flowens is highly effective in alleviating the lower urinary tract symptoms typically associated with BPH, a condition that troubles millions of men across Europe, said Dan Souza, senior dire